Argá Medtech SA is a privately held medical device company based in Switzerland that develops advanced energy delivery systems and cardiac medical technologies.
Subscribe to see Argá Medtech’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Argá Medtech is a medical technology company headquartered in Switzerland. Its most recent funding round, Series B, raised $58.6M in February 2024. Xcout tracks 4 named people at Argá Medtech, including Steven McQuillan (Chief Clinical, Regulatory & Quality Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $58.6M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Argá Medtech's closest competitors — see the full list of competitors and alternatives →
EBAMed is a Swiss medical technology company based in Geneva that develops innovative solutions, including ultrasound imaging and image guidance systems, to enable the non-invasive treatment of heart arrhythmias using external beam radiotherapy.
5th Medical, Inc. is a medical technology company focused on developing innovations in the cardiovascular sector. The company advances new solutions and technologies for cardiovascular care.
CorFlow Therapeutics AG is a clinical-stage medical device company headquartered in Baar, Switzerland, with subsidiary operations in Italy and the United States. The company focuses on transforming the diagnosis and treatment of coronary microvascular disorders through technologies like the CoFI-System.
Aortyx is a biotechnology and medical device company headquartered in Barcelona, Spain, focusing on solutions for hospitals and healthcare.
Pulsify Medical is a cardiovascular medical technology company based in Leuven, Belgium, that develops novel ultrasound solutions and devices.
Life Tech Inc. develops and manufactures innovative interventional medical devices for healthcare providers and patients. Its product and solution portfolios focus primarily on structural heart diseases, peripheral vascular diseases, and cardiac rhythm management.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.